Recombinant antibodies such as nanobodies are progressively demonstrating to be a valid alternative to conventional monoclonal antibodies also for clinical applications. Furthermore, they do not ...

2020). Mutations affecting the core splicing machinery can also cause disease. Since core spliceosome components are, by definition, required constitutively in every cell, their disruption usually ...